Three patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2033. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2033
Next term end
2
Patent families
When these terms end
Each bar runs from grant to computed term end. 2020 to 2037.
US 11,835,530
Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth
Mar 12, 2033
20242028203220362037
3 pending applications: term is not computable until grant.Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Mar 2033 · High confidence
Also notable
Ends Feb 2037 · High confidence
Treatment of Spontaneous Preterm Birth
US 10,928,402
A family of 5 related applications built on the 2021 grant. Protection runs to 2033.
Treatment of Spontaneous Preterm Birth
US 10,877,046
Granted 2020. Computed term ends 2037.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 5, 2027The maintenance fee for Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth (US 11,835,530) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Treatment of Spontaneous Preterm Birth (2015) | 2 in force | to Mar 2033 |
| Treatment of Spontaneous Preterm Birth (2018) | 1 in force | to Feb 2037 |
Patents held now
Soonest term end first.
Showing 1 to 3 of 3
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,928,402 | Treatment of Spontaneous Preterm Birth In force · High confidence | In force | High confidence | |
| US 11,835,530 | Detection of Microparticle-Associated Proteins Associated with Spontaneous Preterm Birth In force · High confidence | In force | High confidence | |
| US 10,877,046 | Treatment of Spontaneous Preterm Birth In force · High confidence | In force | High confidence |
Also on record, not counted in the 3: 3 applications pending · 7 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.